These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28351328)
1. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway. Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328 [TBL] [Abstract][Full Text] [Related]
2. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage. Li G; Lu C; Gao J; Wang X; Wu H; Lee C; Xing B; Zhang Q Int J Clin Exp Pathol; 2015; 8(6):6512-8. PubMed ID: 26261529 [TBL] [Abstract][Full Text] [Related]
3. MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway. Wang C; Kuang L; Han L J Reprod Immunol; 2021 Feb; 143():103265. PubMed ID: 33360511 [TBL] [Abstract][Full Text] [Related]
4. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells. Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860 [TBL] [Abstract][Full Text] [Related]
5. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer. Heeren AM; Koster BD; Samuels S; Ferns DM; Chondronasiou D; Kenter GG; Jordanova ES; de Gruijl TD Cancer Immunol Res; 2015 Jan; 3(1):48-58. PubMed ID: 25361854 [TBL] [Abstract][Full Text] [Related]
6. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area. Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490 [TBL] [Abstract][Full Text] [Related]
7. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection. Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043 [TBL] [Abstract][Full Text] [Related]
8. PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor. Shi L; Chen L; Wu C; Zhu Y; Xu B; Zheng X; Sun M; Wen W; Dai X; Yang M; Lv Q; Lu B; Jiang J Clin Cancer Res; 2016 Mar; 22(5):1173-1184. PubMed ID: 26933175 [TBL] [Abstract][Full Text] [Related]
10. Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type. Jo JC; Kim M; Choi Y; Kim HJ; Kim JE; Chae SW; Kim H; Cha HJ Ann Hematol; 2017 Jan; 96(1):25-31. PubMed ID: 27696202 [TBL] [Abstract][Full Text] [Related]
11. Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children. Xi X; Liu JM; Guo JY Int Arch Allergy Immunol; 2018; 176(3-4):255-267. PubMed ID: 29874664 [TBL] [Abstract][Full Text] [Related]
12. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment. Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860 [TBL] [Abstract][Full Text] [Related]
13. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma. Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153. Baban B; Liu JY; Qin X; Weintraub NL; Mozaffari MS PLoS One; 2015; 10(4):e0124059. PubMed ID: 25902191 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of PD-1 on CD4⁺CD25⁺ T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis. La X; Zhang F; Li Y; Li J; Guo Y; Zhao H; Pang N; Ma X; Wen H; Fan H; Ding J Int Immunopharmacol; 2015 Jun; 26(2):357-66. PubMed ID: 25907244 [TBL] [Abstract][Full Text] [Related]
16. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887 [TBL] [Abstract][Full Text] [Related]
17. Let‑7a suppresses cell proliferation via the TGF‑β/SMAD signaling pathway in cervical cancer. Wu T; Chen X; Peng R; Liu H; Yin P; Peng H; Zhou Y; Sun Y; Wen L; Yi H; Li A; Zhang Z Oncol Rep; 2016 Dec; 36(6):3275-3282. PubMed ID: 27748903 [TBL] [Abstract][Full Text] [Related]
18. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1. Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520 [TBL] [Abstract][Full Text] [Related]
19. Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion. Ma Q; Zhao M; Wei X; Zhao J; Yang T; Zhang Q; Wang K; Yang X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):128-132. PubMed ID: 28270295 [TBL] [Abstract][Full Text] [Related]
20. [Qiyusanlong decoction inhibits the level of PD-1/PD-L1 in mice bearing Lewis lung carcinoma]. Zhang X; Tong J; Li Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):770-4. PubMed ID: 27371844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]